...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: Booyah ! I told you all!!

I respect all the relevant information you have brought to the board however i cannot dismiss my analysis which i posted over two weeks ago. Top line success or not i guaranteed profit taking would occur pre top line announcement as well as short selling overwhelming the bid. On top of that we have more dilution which CLEARLY is not sitting well with current shareholders. I told you all to take profits and rebalance...

New Message
Please login to post a reply